19th Oct 2020 09:48
Ap19
FORM 8.3 - Amendment to Purchase and Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 14 October 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD |
|
| ||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
2,567,346 | 1.99% | 468,287 | 0.36% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
594,656 | 0.46% | 388,524 | 0.30% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
3,162,002 | 2.45% | 856,811 | 0.66% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1 | 213.1200 USD |
| Purchase | 1 | 212.3600 USD |
| Purchase | 9 | 212.9700 USD |
| Purchase | 71 | 213.0300 USD |
| Purchase | 76 | 213.4600 USD |
| Purchase | 84 | 213.9700 USD |
| Purchase | 88 | 213.1100 USD |
| Purchase | 91 | 213.2274 USD |
| Purchase | 100 | 212.9600 USD |
| Purchase | 100 | 212.8800 USD |
| Purchase | 100 | 214.3200 USD |
| Purchase | 185 | 213.6105 USD |
| Purchase | 190 | 212.5764 USD |
| Purchase | 200 | 213.3850 USD |
| Purchase | 200 | 213.2625 USD |
| Purchase | 227 | 212.5500 USD |
| Purchase | 495 | 213.1393 USD |
| Purchase | 775 | 213.0199 USD |
| Purchase | 924 | 212.7711 USD |
| Purchase | 1,320 | 212.9679 USD |
| Purchase | 1,472 | 212.5300 USD |
| Purchase | 1,801 | 213.0352 USD |
| Purchase | 2,377 | 212.5425 USD |
| Purchase | 2,671 | 213.0132 USD |
| Purchase | 4,310 | 213.4722 USD |
| Purchase | 6,010 | 213.3334 USD |
| Purchase | 6,540 | 213.0091 USD |
| Purchase | 6,739 | 212.6699 USD |
| Purchase | 10,621 | 213.0160 USD |
| Purchase | 12,975 | 213.1448 USD |
| Purchase | 13,580 | 213.4109 USD |
| Purchase | 18,080 | 212.6954 USD |
| Sale | 42 | 212.6400 USD |
| Sale | 50 | 212.9700 USD |
| Sale | 91 | 213.2274 USD |
| Sale | 100 | 212.6600 USD |
| Sale | 185 | 213.6105 USD |
| Sale | 192 | 212.5781 USD |
| Sale | 213 | 212.5438 USD |
| Sale | 276 | 213.4057 USD |
| Sale | 344 | 212.9408 USD |
| Sale | 377 | 212.7315 USD |
| Sale | 688 | 212.5996 USD |
| Sale | 760 | 213.2861 USD |
| Sale | 1,036 | 213.4773 USD |
| Sale | 1,078 | 212.9172 USD |
| Sale | 1,119 | 212.6894 USD |
| Sale | 1,324 | 213.2600 USD |
| Sale | 1,335 | 213.8022 USD |
| Sale | 1,472 | 212.5300 USD |
| Sale | 1,546 | 213.1866 USD |
| Sale | 2,057 | 212.6064 USD |
| Sale | 2,377 | 212.5425 USD |
| Sale | 2,382 | 213.0458 USD |
| Sale | 3,275 | 213.3508 USD |
| Sale | 5,516 | 213.3719 USD |
| Sale | 8,452 | 212.4884 USD |
| Sale | 9,765 | 213.4581 USD |
| Sale | 14,333 | 213.1497 USD |
| Sale | 31,750 | 212.9327 USD |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction | Number of relevant securities | Price per |
|
| unit | |
| SWAP | Long | 1 | 344,592,140.0000 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 19 Oct 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201019005322/en/
Copyright Business Wire 2020
Related Shares:
Barclays